{"product_id":"trim25-efp-antibody-sc-f2162","title":"TRIM25\/EFP Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eTRIM25\/EFP is a target of interest in many antibody-based workflows. TRIM25, a member of the tripartite motif (TRIM) family of E3 ubiquitin ligases, is pivotal in regulating innate immune responses, particularly in antiviral defense. It has RING, B-box, and coiled-coil domains that facilitate its E3 ligase activity and interaction with various substrates. TRIM25 activates the RIG-I-like receptor pathway by mediating the K63-linked polyubiquitination of RIG-I, which enhances RIG-I's ability to initiate downstream antiviral signaling and the production of type I interferons. Depending on the literature source, TRIM25\/EFP may also be discussed as TRIM25\/EFP and TRIM25.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following TRIM25\/EFP across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eTRIM25\/EFP is commonly interpreted in the context of immunology, infectious disease, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cytoplasm and nucleus across matched conditions\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003ehost-response changes during infection or pathogen-associated stimulation\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for TRIM25\/EFP. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in TRIM25\/EFP reflect biology rather than handling. When interpreting TRIM25\/EFP, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep TRIM25\/EFP trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577878126937,"sku":"F2162-20UL","price":149.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577878159705,"sku":"F2162-100UL","price":329.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577878192473,"sku":"F2162-2X100UL","price":489.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2162-IF.png?v=1773600236","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/trim25-efp-antibody-sc-f2162","provider":"Absource Diagnostics","version":"1.0","type":"link"}